At a glance
ClinicalIndex Comparison RecordN/ACompleted· 53 enrolled
Drug / intervention
MultiPole Pacingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
QP ExCELs: MultiPole Pacing (MPP) Sub-Study
In Brief
A clinical study evaluating MultiPole Pacing for Heart Failure. Completed, enrolled 53 participants across 44 sites.
Detailed Summary
The objective of this MultiPole Pacing (MPP) sub-study of the QP ExCELs study is to demonstrate that the MPP feature is effective by converting a percentage of cardiac resynchronization therapy (CRT) non-responders to responders. The MPP sub-study is a single-arm, multi-center, prospective trial within the ongoing QP ExCELs study (NCT02290028).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedMay 2017
Enrollment StartMay 2017
Primary CompletionJan 2020
TodayJul 2026
First PostedMay 16, 2017
Enrollment StartMay 19, 2017
Primary CompletionJan 23, 2020
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 9.1 years ago
Interventions
MultiPole Pacingdevice
CRT non-responders are programmed with MultiPole pacing ON.